Detalles de la búsqueda
1.
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Lancet Oncol
; 25(2): 198-211, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38301689
2.
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer.
Br J Cancer
; 124(4): 786-796, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33223535
3.
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
Lancet Oncol
; 21(12): 1620-1629, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33271092
4.
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 19(4): 562-578, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29611518
5.
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
Br J Cancer
; 119(11): 1332-1338, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30420616
6.
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.
J Clin Oncol
; : JCO2301326, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547438
7.
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies.
J Clin Oncol
; : JCO2301648, 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38484206
8.
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
J Exp Clin Cancer Res
; 43(1): 64, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38424636
9.
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS).
Clin Colorectal Cancer
; 22(2): 231-237, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36967267
10.
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets.
J Pathol Clin Res
; 9(6): 449-463, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37697694
11.
Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer.
JNCI Cancer Spectr
; 5(1)2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34159294
12.
Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis.
Clin Colorectal Cancer
; 20(3): 236-244, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33992542
13.
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin.
J Clin Oncol
; 39(36): 4009-4019, 2021 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34752136
14.
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer.
J Clin Oncol
; 39(6): 631-641, 2021 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33439695
15.
Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer.
J Pathol Clin Res
; 6(4): 283-296, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32401426
16.
Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis.
JAMA Netw Open
; 3(1): e1918939, 2020 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31922558
17.
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer.
J Natl Cancer Inst
; 111(8): 828-836, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30649440
18.
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Health Technol Assess
; 23(64): 1-88, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31852579
Resultados
1 -
18
de 18
1
Próxima >
>>